Fenofibrate: Difference between revisions
imported>David E. Volk (New page: {{subpages}} right|thumb|350px|{{#ifexist:Template:Fenofibrate structure.jpg/credit|{{Fenofibrate structure.jpg/credit}}<br/>|}}Fenofibrate. '''Fenofi...) |
imported>David E. Volk No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
[[Image:Fenofibrate structure.jpg|right|thumb| | [[Image:Fenofibrate structure.jpg|right|thumb|200px|{{#ifexist:Template:Fenofibrate structure.jpg/credit|{{Fenofibrate structure.jpg/credit}}<br/>|}}Fenofibrate.]] | ||
'''Fenofibrate''', also known as fenofibrato( Spanish), fenofibratum (Latin), FNF and finofibrate, | '''Fenofibrate''', also known as fenofibrato(Spanish), fenofibratum (Latin), FNF and finofibrate, is an antilipemic drug which reduces both [[cholesterol]] and [[triglyceride]]s in the blood. Its IUPAC name is propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate and its chemical formula is C<sub>20</sub>H<sub>21</sub>ClO<sub>4</sub>. [[Fenofibric acid]] is the active metabolite of fenofibrate, that produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII. | ||
| Line 36: | Line 35: | ||
*Tricor | *Tricor | ||
*Triglide | *Triglide | ||
==External Links == | |||
{{DailyMed}} | |||
Drug Bank http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=DB01039.txt | |||
Revision as of 22:38, 24 January 2008
Fenofibrate, also known as fenofibrato(Spanish), fenofibratum (Latin), FNF and finofibrate, is an antilipemic drug which reduces both cholesterol and triglycerides in the blood. Its IUPAC name is propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate and its chemical formula is C20H21ClO4. Fenofibric acid is the active metabolite of fenofibrate, that produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.
Brand Names
- Ankebin
- Antara
- Elasterate
- Elasterin
- Fenobrate
- Fenogal
- Fenotard
- Lipanthyl
- Lipantil
- Lipidex
- Lipidil
- Lipidil Micro
- Lipidil Supra
- Lipifen
- Lipirex
- Lipoclar
- Lipofene
- Liposit
- Lipsin
- Lofibra
- Luxacor
- Nolipax
- Procetofen
- Proctofene
- Protolipan
- Secalip
- Sedufen
- Tricor
- Triglide
External Links
Fenofibrate - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine). Drug Bank http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=DB01039.txt